Research Article
Fibrosis-4 Index Is Closely Associated with Arterial Damage and Future Risk of Coronary Heart Disease in Type 2 Diabetes
Table 1
Clinical characteristics of study subjects.
| | Clinical characteristics | Mean ± SD, n (%) | Range |
| | Sex (men) | 163 (64.4) | | | Age (years) | 65.6 ± 10.9 | 35–86 | | Body mass index | 25.09 ± 4.52 | 14.3–40.1 | | Smoking habit (current) | 55 (21.7) | | | Systolic blood pressure (mmHg) | 130.6 ± 16.8 | 92–181 | | Diastolic blood pressure (mmHg) | 76.4 ± 11.2 | 43–105 | | Hypertension | 195 (77.1) | | | Statin use | 147 (58.1) | | | PLT (×109/L) | 231.9 ± 60.7 | 111–531 | | ALT (IU/L) | 24.8 ± 14.3 | 7–143 | | AST (IU/L) | 26.7 ± 21.6 | 7–232 | | FIB4 index | 1.52 ± 0.74 | 0.36–4.84 | | HDL-CHOL (mmol/L) | 1.41 ± 0.45 | 0.65–3.81 | | LDL-CHOL (mmol/L) | 2.66 ± 0.84 | 0.85–8.86 | | Triglyceride (mmol/L) | 1.55 ± 0.98 | 0.36–7.91 | | Uric acid (µmol/L) | 325.5 ± 77.8 | 59.5–630.5 | | eGFR (mL/min/1.73 m2) | 74.14 ± 25.16 | 14.9–176.9 | | HbA1c (%) | 7.95 ± 1.88 | 5.6–18.3 |
|
|
SD, standard deviation; PLT, platelet; ALT, alanine aminotransferase, AST, aspartate aminotransferase; FIB4 index, fibrosis-4 index; HDL-CHOL, high-density lipoprotein cholesterol; LDL-CHOL, low-density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; HbA1c, glycosylated hemoglobin.
|
